Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cellular Immunology|April 15, 1994
In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytesM Nakashima, T Watanabe, H Koprowski, et al.Seminars in Oncology|May 29, 1999
Pharmacokinetics of amifostine: effects of dose and method of administrationL M Shaw, H S Bonner, L Schuchter, et al.Hybridoma|June 1, 1994
Proliferation, phenotype, and cytotoxicity of human lymphocytes isolated from lymph nodes invaded by melanoma cellsM Nakashima, M Janiszewska, Z Steplewski, et al.The Journal of Surgical Research|April 1, 1992
Anti-neoplastic effects of interleukin-4H P Redmond, L Schuchter, D Bartlett, et al.Archives of Dermatology|January 6, 1999
Validation of a melanoma prognostic modelD J Margolis, A C Halpern, T Rebbeck, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 16, 2002
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancerK D Miller, W Gradishar, L Schuchter, et al.Medical Oncology (Northwood, London, England)|November 20, 1998
Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferonR K Alpaugh, M von Mehren, I Palazzo, et al.Annals of Internal Medicine|September 1, 1996
A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion GroupL Schuchter, D J Schultz, M Synnestvedt, et al.Annals of Plastic Surgery|May 16, 2001
Locally recurrent malignant melanoma characteristics and outcomes: a single-institution studyJ K Wildemore, L Schuchter, R Mick, et al.Pageof 2